slotkoers
Amman S.E.
00:00:00 05-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
1,36
JOD
|
-1,45%
|
|
0,00%
|
-4,90%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
11,85
|
11,7
|
10,72
|
10,28
|
10,42
|
10,72
|
Bedrijfswaarde
1 |
12,27
|
12,63
|
10,78
|
10,06
|
10,76
|
10,82
|
K/w-verhouding
|
11,7
x
|
9,19
x
|
75,7
x
|
25
x
|
14,9
x
|
13,3
x
|
Dividendrendement
|
3,16%
|
-
|
-
|
4,38%
|
4,32%
|
4,9%
|
Marktkapitalisatie/omzet
|
1,48
x
|
1,28
x
|
1,39
x
|
1,56
x
|
1,24
x
|
1,28
x
|
Bedrijfswaarde/omzet
|
1,53
x
|
1,39
x
|
1,4
x
|
1,52
x
|
1,28
x
|
1,29
x
|
Bedrijfswaarde/EBITDA
|
7,91
x
|
6,23
x
|
14,4
x
|
11,4
x
|
8,83
x
|
6,56
x
|
Bedrijfswaarde/FCF
|
13,5
x
|
-24,8
x
|
8,85
x
|
-61,6
x
|
-38,2
x
|
20,8
x
|
FCF Yield
|
7,39%
|
-4,04%
|
11,3%
|
-1,62%
|
-2,62%
|
4,8%
|
Price to Book
|
1,1
x
|
1
x
|
0,94
x
|
0,85
x
|
0,84
x
|
0,84
x
|
Aantal aandelen (in duizenden)
|
7.500
|
7.500
|
7.500
|
7.500
|
7.500
|
7.500
|
Referentieprijs
2 |
1,580
|
1,560
|
1,430
|
1,370
|
1,390
|
1,430
|
Datum van publicatie
|
17/03/19
|
9/03/20
|
7/06/21
|
3/03/22
|
16/03/23
|
11/02/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
8
|
9,115
|
7,697
|
6,601
|
8,415
|
8,405
|
EBITDA
1 |
1,551
|
2,026
|
0,7481
|
0,8793
|
1,218
|
1,649
|
Bedrijfsresultaat (EBIT)
1 |
1,277
|
1,692
|
0,4689
|
0,7192
|
1,098
|
1,355
|
Operationele Marge
|
15,96%
|
18,56%
|
6,09%
|
10,89%
|
13,05%
|
16,12%
|
Resultaat voor belastingen (EBT)
1 |
1,069
|
1,43
|
0,1667
|
0,4939
|
0,8656
|
1,022
|
Nettowinst (verlies)
1 |
1,009
|
1,274
|
0,1417
|
0,4102
|
0,7011
|
0,8072
|
Nettomarge
|
12,61%
|
13,97%
|
1,84%
|
6,21%
|
8,33%
|
9,6%
|
WPA
2 |
0,1345
|
0,1698
|
0,0189
|
0,0547
|
0,0935
|
0,1076
|
Free Cash Flow
1 |
0,9069
|
-0,5099
|
1,217
|
-0,1633
|
-0,2815
|
0,5191
|
FCF-marge
|
11,34%
|
-5,59%
|
15,82%
|
-2,47%
|
-3,34%
|
6,18%
|
Kasstroomconversie (ebitda)
|
58,49%
|
-
|
162,71%
|
-
|
-
|
31,48%
|
Kasstroomconversie (nettowinst)
|
89,92%
|
-
|
859,01%
|
-
|
-
|
64,3%
|
Dividend per aandeel
2 |
0,0500
|
-
|
-
|
0,0600
|
0,0600
|
0,0700
|
Datum van publicatie
|
17/03/19
|
9/03/20
|
7/06/21
|
3/03/22
|
16/03/23
|
11/02/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
0,42
|
0,93
|
0,05
|
-
|
0,33
|
0,09
|
Nettokaspositie
1 |
-
|
-
|
-
|
0,21
|
-
|
-
|
Hefboom (schuld/ebitda)
|
0,2716
x
|
0,4591
x
|
0,0674
x
|
-
|
0,2722
x
|
0,0559
x
|
Free Cash Flow
1 |
0,91
|
-0,51
|
1,22
|
-0,16
|
-0,28
|
0,52
|
ROE (netto-inkomsten/eigen vermogen)
|
9,63%
|
11,3%
|
1,23%
|
3,48%
|
5,72%
|
6,42%
|
ROA (netto-inkomsten/totale activa)
|
5,91%
|
7,1%
|
1,89%
|
2,99%
|
4,44%
|
5,32%
|
Totale activa
1 |
17,06
|
17,92
|
7,506
|
13,73
|
15,78
|
15,18
|
Nettoactief per aandeel
2 |
1,440
|
1,560
|
1,530
|
1,620
|
1,650
|
1,700
|
Cashflow per aandeel
2 |
0,1300
|
0,1600
|
0,2100
|
0,2200
|
0,2000
|
0,1900
|
Capex
1 |
0,36
|
0,27
|
0,14
|
0,2
|
0,17
|
0,07
|
Capex/omzet
|
4,44%
|
2,99%
|
1,81%
|
3,1%
|
1,98%
|
0,78%
|
Datum van publicatie
|
17/03/19
|
9/03/20
|
7/06/21
|
3/03/22
|
16/03/23
|
11/02/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -4,90% | 14,39 mln. | | +22,35% | 44,12 mld. | | +22,22% | 22,61 mld. | | +17,81% | 15,11 mld. | | +15,73% | 13,61 mld. | | +57,91% | 13,34 mld. | | -8,98% | 6,94 mld. | | -0,05% | 6,79 mld. | | +15,65% | 5,75 mld. | | -8,87% | 5,73 mld. |
Generieke geneesmiddelen
|